文献速递心脏核医学肿瘤 PET/CT

非酒精性脂肪肝与18F-FDG PET测得心肌葡萄糖摄取的相关性

Association between non-alcoholic fatty liver disease and myocardial glucose uptake measured by 18F-fluorodeoxyglucose positron emission tomography.
PubMed 文献 · J Nucl Cardiol · 2018-09-20

回顾性纳入743例无症状受试者(201例非酒精性脂肪肝,542例无脂肪肝),用18F-FDG PET计算心肌最大摄取与肝脏平均标准化摄取值之比(SUVratio)评估心肌葡萄糖摄取。非酒精性脂肪肝组心肌葡萄糖摄取显著低于无脂肪肝组(P<.001),SUVratio四分位与肝脂肪变呈强负相关(P<.001),且心肌葡萄糖摄取较低的非酒精性脂肪肝患者左室充盈压升高比例更高(P<.05)。

要点

  • 非酒精性脂肪肝患者心肌葡萄糖摄取较无脂肪肝者显著降低(P<.001)。
  • SUVratio四分位与肝脂肪变程度呈强负相关(P<.001)。
  • 心肌葡萄糖摄取较低的非酒精性脂肪肝患者左室充盈压升高比例更高(P<.05)。

核心结论

  • 在其余方面健康的受试者中,非酒精性脂肪肝的存在与18F-FDG PET评估的心肌葡萄糖摄取降低密切相关。
  • 心肌葡萄糖摄取较低的非酒精性脂肪肝个体更可能有舒张性心功能受损的高风险。

研究设计与样本

  • 回顾性研究,共纳入743例无症状受试者,其中非酒精性脂肪肝201例、无脂肪肝542例。
  • 采用18F-FDG PET计算心肌最大摄取与肝脏平均标准化摄取值之比(SUVratio)评估心肌葡萄糖摄取。
  • 脂肪肝诊断及分级由平扫CT依据既往研究诊断标准确认,心肌几何与功能数据由超声心动图获得。

主要发现

  • 非酒精性脂肪肝组心肌葡萄糖摄取显著低于无脂肪肝组(P<.001)。
  • SUVratio四分位与肝脂肪变呈强负相关(P<.001)。
  • 心肌葡萄糖摄取较低的非酒精性脂肪肝患者左室充盈压升高比例更高(P<.05)。
  • 趋势分析显示心肌SUVratio与E/e'比值之间存在显著关系(P<.05)。
  • 多因素回归分析校正临床重要因素后,心肌葡萄糖摄取与非酒精性脂肪肝独立相关(所有P<.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) has emerged as an independent risk factor for cardiovascular diseases. However, there were few studies evaluating the condition of myocardial glucose metabolism in patients with NAFLD. Therefore, the aim of this study was to investigate the association between NAFLD and myocardial glucose uptake assessed by using 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET) and whether or not alteration of myocardial glucose uptake could be an indicator linking to cardiac dysfunction in NAFLD individuals. METHODS AND RESULTS: A total of 743 asymptomatic subjects (201 with NAFLD, 542 without NAFLD) were retrospectively studied. The ratio of maximum myocardium FDG uptake to the mean standardized uptake value of liver (SUVratio) was calculated to estimate myocardial glucose uptake by using 18F-FDG PET. The diagnosis of fatty liver and fatty liver grading was confirmed by unenhanced CT according to diagnostic criterion of previous studies. The myocardial geometric and functional data were obtained by echocardiogram. Myocardial glucose uptake was significantly lower in individuals with NAFLD compared with those without fatty liver (P < .001). When analysis of association trend was performed, SUVratio quartiles showed correlated inversely and strongly with liver steatosis (P < .001). NAFLD patients with lower myocardial glucose uptake were more likely to have higher proportion of increased LV filling pressure (P < .05). A significant relationship between myocardial SUVratio and E/e' ratio was presented in the trend analysis (P < .05). Moreover, multivariate regression analysis showed that myocardial glucose uptake was independently associated with NAFLD after adjusting for clinical important factors (all P < .001). CONCLUSIONS: The presence of NAFLD in otherwise healthy subjects is closely associated with decreased myocardial glucose uptake assessing by 18F-FDG PET imaging. Furthermore, the NAFLD individuals with lower myocardial glucose uptake are more likely to have high risk of having impaired diastolic heart function.

来源:J Nucl Cardiol,查看原文。版权归原作者所有。

引用

  1. Tang K, Zheng X, Lin J, et al. Association between non-alcoholic fatty liver disease and myocardial glucose uptake measured by 18F-fluorodeoxyglucose positron emission tomography. J Nucl Cardiol. 2018. PMID: 30238301. doi:10.1007/s12350-018-1446-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。